Vaccines, blood, antisera, toxins and cultures in Belgium | The Observatory of Economic Complexity

About

Exports In 2022, Belgium exported $47.1B in Vaccines, blood, antisera, toxins and cultures, making it the 2nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most exported product in Belgium. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Belgium are: United States ($9.38B), Germany ($7.86B), Japan ($6.02B), United Kingdom ($2.72B), and France ($2.59B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Belgium between 2021 and 2022 were United States ($2.29B), Japan ($1.33B), and France ($662M).

Imports In 2022, Belgium imported $20.7B in Vaccines, blood, antisera, toxins and cultures, becoming the 3rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Belgium. Belgium imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($9.85B), France ($2.72B), United States ($1.9B), Switzerland ($1.61B), and Italy ($1.4B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Belgium between 2021 and 2022 were Ireland ($3.91B), France ($366M), and Italy ($63.4M).

Latest Trends

July 2024

About

Overview In July 2024 Belgium's Vaccines, blood, antisera, toxins and cultures exports accounted up to €2.36B and imports accounted up to €1.27B, resulting in a positive trade balance of €1.09B. Between July 2023 and July 2024 the exports of Belgium's Vaccines, blood, antisera, toxins and cultures have increased by €434M (22.5%) from €1.93B to €2.36B, while imports decreased by €-1.45B (-53.3%) from €2.73B to €1.27B.

Destinations In July 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (€622M), United Kingdom (€356M), Germany (€254M), France (€163M), and Spain (€91.3M), and were imported mostly from Switzerland (€560M), Ireland (€241M), United States (€154M), Germany (€80.5M), and Singapore (€54.3M).

Growth In July 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to United States (€368M or 558%), Japan (€204M or 2.94k%), and United Kingdom (€86.1M or 211%). In July 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from Ireland (€-1.12B or -64.5%), Italy (€-106M or -73.3%), and Singapore (€-15.4M or -52.3%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (July 2023 - July 2024)€434M(22.5%)

IMPORT GROWTH (July 2023 - July 2024)€-1.45B(-53.3%)

MAIN DESTINATION (July 2024)United States€622M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Belgium. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download